Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS/ERK signaling pathwayChenghui Zhou, Jia Shi, Zhongrong Fang et al.|Journal of Molecular and Cellular Cardiology|2019Cited by 43
Efficacy, Safety, and Immunogenicity of HLX04Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatmentfor Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase IIIStudyShukui Qin, Jiemin Zhao, Jin Li et al.|BioDrugs|2021Cited by 29